John D. Diekman is a founding partner at 5AM Ventures who invests $100K–$5M in seed to Series B biotech and healthcare. See sector focus and contact routes.
John D. Diekman is a founding partner at 5AM Ventures who invests $100K–$5M in seed to Series B biotech and healthcare companies focused on scientific innovation and cutting-edge medicine. His firm specializes in early-stage life sciences, building biotechnology companies that are often too young for larger venture funds and require hands-on assistance. Notable portfolio and board affiliations include Repare Therapeutics, Cleave Therapeutics, Wildcat Discovery Technologies, and IDEAYA Biosciences, reflecting a thesis on advancing biopharmaceutical therapeutics and platform technologies.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in San Francisco when building a target list.
Investors like John D. Diekman · Full investor directory · Investor access · Company funding database